Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
20/20 Biolabs, Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AIDX
Nasdaq
3850
2020biolabs.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 20/20 Biolabs, Inc.
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch
- Sep 5th, 2026 8:14 pm
Healwell AI (TSX:AIDX) Stock Draws Fresh Price Target Split After Quarterly Results
- Sep 5th, 2026 11:06 am
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
- Aug 28th, 2026 4:26 pm
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
- Aug 26th, 2026 6:31 am
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
- Aug 17th, 2026 6:31 am
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
- Jul 30th, 2026 6:31 am
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
- Jul 27th, 2026 2:30 pm
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
- Jul 23rd, 2026 6:31 am
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth
- Jul 9th, 2026 2:01 pm
Healwell AI (TSX:AIDX) Stock Fair Value Falls As Analysts Trim Growth Assumptions
- Jun 26th, 2026 5:07 pm
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
- Jun 22nd, 2026 2:45 pm
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
- May 27th, 2026 6:31 am
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
- May 22nd, 2026 6:31 am
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
- May 20th, 2026 2:05 pm
Sidoti Events, LLC's May Micro-Cap Virtual Conference
- May 20th, 2026 5:30 am
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
- May 14th, 2026 6:31 am
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
- Apr 13th, 2026 5:00 am
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- Apr 10th, 2026 8:00 am
Scroll